authorBy Nouriel Roubini
DateJul 07, 2026
Read time2 min
This report delves into the remarkable performance of the U.S. banking sector during June, highlighting the key drivers behind its significant market rally and contrasting it with the broader market's decline. It provides an in-depth look at the S&P US BMI Banks index, offering crucial insights into its total return and the substantial increase in the median price-to-adjusted tangible book value. This analysis aims to shed light on the sector's robust health and investor sentiment, making it a valuable read for anyone interested in financial markets.
U.S. Banks Outperform: June's Financial Triumph
The Ascent of American Financial Institutions in June's Market
June witnessed a pronounced upswing across the American banking industry, as financial stocks demonstrated a widespread rally. This period marked a significant positive shift in market dynamics for banks, distinguishing their performance from other sectors.
The S&P US BMI Banks Index: A Beacon of Growth
During June, the market cap-weighted S&P US BMI Banks index recorded an impressive total return of 9.3%. This substantial gain stands in stark contrast to the S&P 500, which saw a 1% decrease over the same month, underscoring the banking sector's exceptional strength and resilience.
Valuation Metrics: A Leap in Price-to-Adjusted Tangible Book Value
Further analysis of bank valuations revealed a significant increase in the median price-to-adjusted tangible book value. This metric climbed to 159.5% by June 30, a notable rise from 147.3% recorded on May 29, and a substantial improvement from 140.0% at the close of 2025. This upward trajectory indicates growing investor confidence and a positive outlook for the banking sector's intrinsic value.
Finance
Alpha Tau Medical: Alpha Particles Still Interesting But Beware The Hype
Alpha Tau Medical (DRTS) is pioneering alpha emitter-based targeted radiation therapy, aiming for highly localized tumor destruction with minimal systemic toxicity. The company's Alpha DaRT platform is advancing in recurrent cutaneous squamous cell carcinoma, with pivotal ReSTART trial top-line data expected in late H2 2026. Despite promising early data, DRTS's valuation appears ahead of clinical evidence, warranting caution amid significant logistical and commercial risks.
By Michele FerreroJul 07, 2026
FinanceInvestment Philosophy: Prioritizing Risk Management and Undervalued Assets
This article discusses Stone Sentinel Capital's (SSC) investment strategy, which prioritizes undervalued and unpopular stocks over popular ones, aiming for long-term outperformance. It highlights SSC's Q2 2026 performance, where it gained 7.6% against the S&P 500's 10.2%, emphasizing that short-term returns are less indicative of success than a consistent, value-driven approach. The piece also delves into the risks of investing in highly popular sectors like AI, advocating for a focus on intrinsic value and a robust investment process rather than merely chasing high returns.
By Lisa JingJul 07, 2026
FinanceGlobal Market Dynamics: SpaceX's Nasdaq Debut, Chip Stock Declines, and Rising Oil Prices
Global stock markets experienced a mixed opening with the Nasdaq Composite impacted by chip stock declines, while the Dow Jones Industrial Average reached a new high. Fiserv shares surged on acquisition rumors, and SpaceX made its Nasdaq 100 debut. Oil prices rose due to geopolitical tensions, and the 10-year Treasury yield increased. Uncertainty in monetary policy and elevated geopolitical risks are key market drivers, with investors awaiting clearer economic signals.
By Strive MasiyiwaJul 07, 2026
FinanceClearBridge Large Cap Growth Strategy: Navigating Evolving Markets in Q2 2026
In the second quarter of 2026, equity markets surged due to strong corporate earnings and reduced geopolitical tensions. ClearBridge Investments' Large Cap Growth Strategy adapted to significant market shifts, including the Russell U.S. Indexes Reconstitution and SpaceX's historic IPO. The Strategy transitioned to a non-diversified mandate, enhancing flexibility in portfolio management. Despite short-term underperformance, ClearBridge remains confident in its ability to generate alpha by recalibrating AI exposures and capitalizing on potential market broadening.
By Robert KiyosakiJul 07, 2026
FinanceGrayscale Ethereum Trust: A Deep Dive into Staking Yields and Fee Discrepancies
Grayscale Ethereum Trust (ETHE) currently holds a 'Hold' rating due to its staking yield, which has narrowed its fee disadvantage to 23 basis points compared to rival offerings. Despite a 2.02% staking yield mitigating a significant portion of its 2.50% fee, the variable nature of this yield introduces uncertainty. Persistent negative investor flows and a shift towards lower-fee alternatives from competitors, including Grayscale’s own Staking Mini ETF, suggest a lack of compelling reasons for new investment, warranting a cautious stance.
By Michele FerreroJul 07, 2026